These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 23289598)

  • 1. Oncolytic measles virus strains as novel anticancer agents.
    Msaouel P; Opyrchal M; Domingo Musibay E; Galanis E
    Expert Opin Biol Ther; 2013 Apr; 13(4):483-502. PubMed ID: 23289598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated oncolytic measles virus strains as cancer therapeutics.
    Msaouel P; Iankov ID; Dispenzieri A; Galanis E
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1732-41. PubMed ID: 21740361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic measles virus retargeting by ligand display.
    Msaouel P; Iankov ID; Allen C; Russell SJ; Galanis E
    Methods Mol Biol; 2012; 797():141-62. PubMed ID: 21948475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential and clinical translation of oncolytic measles viruses.
    Robinson S; Galanis E
    Expert Opin Biol Ther; 2017 Mar; 17(3):353-363. PubMed ID: 28129716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview.
    Msaouel P; Dispenzieri A; Galanis E
    Curr Opin Mol Ther; 2009 Feb; 11(1):43-53. PubMed ID: 19169959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles virus as an oncolytic vector platform.
    Blechacz B; Russell SJ
    Curr Gene Ther; 2008 Jun; 8(3):162-75. PubMed ID: 18537591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles virus for cancer therapy.
    Russell SJ; Peng KW
    Curr Top Microbiol Immunol; 2009; 330():213-41. PubMed ID: 19203112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation in Oncolytic Measles Virotherapy.
    Dietz L; Engeland CE
    Methods Mol Biol; 2020; 2058():111-126. PubMed ID: 31486034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered measles virus as a novel oncolytic therapy against prostate cancer.
    Msaouel P; Iankov ID; Allen C; Morris JC; von Messling V; Cattaneo R; Koutsilieris M; Russell SJ; Galanis E
    Prostate; 2009 Jan; 69(1):82-91. PubMed ID: 18973133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects.
    Msaouel P; Opyrchal M; Dispenzieri A; Peng KW; Federspiel MJ; Russell SJ; Galanis E
    Curr Cancer Drug Targets; 2018; 18(2):177-187. PubMed ID: 28228086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of oncolytic measles virus: promises and challenges.
    Galanis E
    Clin Pharmacol Ther; 2010 Nov; 88(5):620-5. PubMed ID: 20881957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine.
    Grossardt C; Engeland CE; Bossow S; Halama N; Zaoui K; Leber MF; Springfeld C; Jaeger D; von Kalle C; Ungerechts G
    Hum Gene Ther; 2013 Jul; 24(7):644-54. PubMed ID: 23642239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles to the Rescue: A Review of Oncolytic Measles Virus.
    Aref S; Bailey K; Fielding A
    Viruses; 2016 Oct; 8(10):. PubMed ID: 27782084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination.
    Baldo A; Galanis E; Tangy F; Herman P
    Hum Vaccin Immunother; 2016 May; 12(5):1102-16. PubMed ID: 26631840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synergistic Effect of NF-κB Signaling Pathway Inhibitor and Oncolytic 
Measles Virus Vaccine Strain against Lung Cancer and Underlying Mechanisms].
    Xia M; Meng G; Dong J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):245-253. PubMed ID: 33775041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic measles virus as a novel therapy for malignant peripheral nerve sheath tumors.
    Deyle DR; Escobar DZ; Peng KW; Babovic-Vuksanovic D
    Gene; 2015 Jul; 565(1):140-5. PubMed ID: 25843626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemovirotherapeutic Treatment Using Camptothecin Enhances Oncolytic Measles Virus-Mediated Killing of Breast Cancer Cells.
    Tai CJ; Liu CH; Pan YC; Wong SH; Tai CJ; Richardson CD; Lin LT
    Sci Rep; 2019 May; 9(1):6767. PubMed ID: 31043633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitophagy enhances oncolytic measles virus replication by mitigating DDX58/RIG-I-like receptor signaling.
    Xia M; Gonzalez P; Li C; Meng G; Jiang A; Wang H; Gao Q; Debatin KM; Beltinger C; Wei J
    J Virol; 2014 May; 88(9):5152-64. PubMed ID: 24574393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.
    Blechacz B; Splinter PL; Greiner S; Myers R; Peng KW; Federspiel MJ; Russell SJ; LaRusso NF
    Hepatology; 2006 Dec; 44(6):1465-77. PubMed ID: 17133484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma.
    Zhang SC; Wang WL; Cai WS; Jiang KL; Yuan ZW
    BMC Cancer; 2012 Sep; 12():427. PubMed ID: 23009685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.